Clinical Trials
25
Trial Phases
4 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (25 trials with phase data)• Click on a phase to view related trials
Study of Concomitant Administration of the sIPV and DTaP or MMR
- Conditions
- PolioDiphteria, Tetanus and PertussisMMR Vaccine
- Interventions
- First Posted Date
- 2025-04-09
- Last Posted Date
- 2025-04-17
- Target Recruit Count
- 2640
- Registration Number
- NCT06920069
- Locations
- 🇨🇳
Lufeng Center for Disease Control and Prevenion, Chuxiong, Yunnan, China
🇨🇳Yuanmou Center for Disease Control and Prevention, Chuxiong, Yunnan, China
🇨🇳Wuding Center for Disease Control and Prevention, Chuxiong, Yunnan, China
Phase III Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
- Conditions
- Influenza, HumanInfluenza, Human PreventionInfluenza aInfluenza BInfluenza Viral Infections
- Interventions
- Biological: QIVBiological: QIV Control
- First Posted Date
- 2025-01-30
- Last Posted Date
- 2025-01-30
- Target Recruit Count
- 4400
- Registration Number
- NCT06800950
- Locations
- 🇨🇳
Xing'an Center for Disease Control and Prevention, Guilin, Guangxi, China
🇨🇳Yangshuo Center for Disease Control and Prevention, Guilin, Guangxi, China
🇨🇳Binyang Center for Disease Control and Prevention, Nanning, Guangxi, China
Phase I Clinical Trial of Quadrivalent Influenza Virus Split Vaccine
- Conditions
- Influenza, HumanInfluenza aInfluenza Type BInfluenza Viral Infections
- Interventions
- Biological: QIVBiological: QIV control
- First Posted Date
- 2024-10-02
- Last Posted Date
- 2025-01-28
- Target Recruit Count
- 180
- Registration Number
- NCT06622590
- Locations
- 🇨🇳
Binyang Center for Disease Control and Prevention, Nanning, Guangxi, China
Phase IV Study of Concomitant Administration of the sIPV and HepA
- Conditions
- PolioHepatitis A
- First Posted Date
- 2024-06-14
- Last Posted Date
- 2024-06-14
- Target Recruit Count
- 2000
- Registration Number
- NCT06460545
- Locations
- 🇨🇳
Jiu Longpo District Center for Disease Control and Disease, Chongqing, Chongqing, China
🇨🇳Wanzhou District Center for DIsease Control and Prevention, Chongqing, Chongqing, China
🇨🇳Jiangjin District Center for Disease Control and Prevention, Chongqing, Chonqing, China
Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine
- Conditions
- PertussisTetanusDiphtheria
- First Posted Date
- 2023-12-28
- Last Posted Date
- 2024-01-03
- Target Recruit Count
- 460
- Registration Number
- NCT06184542
- Locations
- 🇨🇳
Dazhu Center for Disease Prevention and Control, Dazhou, Sichuan, China
🇨🇳Cuiping Center for Disease Prevention and Control, Yibin, Sichuan, China
🇨🇳Xingwen Center for Disease Prevention and Control, Yibin, Sichuan, China
- Prev
- 1
- 2
- 3
- 4
- 5
- Next